Article
The Therapeutic Target and Mechanism of Vitamin A in Patients with Hepatocholangiocarcinoma and SARS-CoV-2
2020-10-13
Abstract excerpt
Objectives: Recent reports indicate patients with hepatocholangiocarcinoma (CHOL) may increase the risk of morbidity and death-rate for coronavirus disease-2019 (SARS-CoV-2). Clinically, anti-CHOL/SARS-CoV-2 medicine is marked scarcity. Vitamin A (VA) refers to a potent nutrient that can achieve anti-cytotoxic and anti-inflammatory actions. Therefore, this study aimed to determine the potential functions and molec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0872926b-a544-57ad-8ff6-47f5917c9f2c
- DOI
- 10.2139/ssrn.3679856
